Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer’s Disease
Crossref DOI link: https://doi.org/10.1007/s40262-017-0608-3
Published Online: 2017-10-23
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hey, John A.
Yu, Jeremy Y.
Versavel, Mark
Abushakra, Susan
Kocis, Petr
Power, Aidan
Kaplan, Paul L.
Amedio, John
Tolar, Martin
License valid from 2017-10-23